We are live on ! Find out more
RP

Regeneron Pharmaceuticals Portfolio holdings

AUM $47.9M
1-Year Est. Return 29.29%
This Fund
S&P 500
This Quarter Est. Return
+43.96%
1 Year Est. Return
+29.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$700M
AUM Growth
-$785M
Cap. Flow
-$1.24B
Cap. Flow %
-177.44%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$1.24B

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ALNY icon
1
Alnylam Pharmaceuticals
ALNY
$38.5B
$635M 90.64%
1,392,303
-3,052,142
-69% -$1.24B
NTLA icon
2
Intellia Therapeutics
NTLA
$1.82B
$64M 9.13%
3,702,995
– –
ADVM
3
DELISTED
Adverum Biotechnologies
ADVM
$820K 0.12%
180,909
– –
ACET icon
4
Adicet Bio
ACET
$79.9M
$784K 0.11%
60,511
– –

Similar funds

PFA
Portland Financial Advisors Port Washington, New York $48.1M AUM 10.13% 1-Year Est. Return
CCG
Capital CS Group Irvine, California $48.4M AUM 11.64% 1-Year Est. Return
IPHI
Inflection Point Holdings II New York $47.3M AUM
FWM
FLP Wealth Management Bentonville, Arkansas $48.5M AUM 23.48% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return
CT
ClearAlpha Technologies Greenwich, Connecticut $48.6M AUM 13.34% 1-Year Est. Return
PEP
Pickering Energy Partners Houston, Texas $47.1M AUM 78.22% 1-Year Est. Return
FCM
Firsthand Capital Management San Jose, California $46.9M AUM 114.33% 1-Year Est. Return